Annotated Medicine and Device Lists


Meglumine antimoniate

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines 2019 6.5.2. Antileishmaniasis medicines No observations

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 01 ANTIPROTOZOARIOS No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 01. ANTIPROTOZOARIOS No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 01. Amebicidas y antihelmínticos Others observations:
Equivalente a 85 mg/mL de antimonio pentavalente (Sb +5) o Meglumina antimoniato 300 mg/mL equivalente a 81 mg/mL de antimonio pentavalente (Sb +5) o Estibogluconato sódico 300 mg/mL equivalente a 100 mg/mL de antimonio pentavalente (Sb +5). Contiene preservante. Solución inyectable. Ampolla con 5 mL
El Salvador - 2019 ANTIPROTOZOARIOS Others observations:
USO EXCLUSIVO DE: INFECTOLOGÍA Y DERMATOLOGÍA
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 P. PRODUTOS ANTIPARASITARIOS, INSECTICIDAS E REPELENTES No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 01. Amebicidas y antihelminticos No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 2.7.1. Antileishmaniasis medicines Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru 6.5.2 Anti-Leishmaniasis No observations

Information Resources: Meglumine antimoniate

Loading ...
Loading ...
Loading ...
No information available